Notice of Special Interest (NOSI): Basic and Translational Research on Circadian Regulation of Heart, Lung, Blood, and Sleep Disorders (R01)
Notice NOT-HL-22-043 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - September 13, 2022 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Pediatric Heart Network Clinical Research Centers (UM1)
Notice NOT-HL-22-045 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 25, 2022 Category: Research Source Type: funding
Rural Health Care Outcomes Accelerator
A 3 year initiative designed to eliminate rural health disparities by helping hospitals and clinicians provide high-quality evidence-based care. Assistance includes free access to evidence-based programs, consultants, networking, and recognition. Geographic coverage: Nationwide -- American Heart Association (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - July 27, 2022 Category: American Health Source Type: funding
Limited Competition for the Continuation of the Chronic Renal Insufficiency Cohort (CRIC) Scientific and Data Coordinating Center (U24 - Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-22-503 from the NIH Guide for Grants and Contracts. The purpose of this Limited Competition is to extend the Chronic Renal Insufficiency Cohort (CRIC) Study by continuing to support the Scientific and Data Coordinating Center (SDCC). The CRIC Study is a multi-center, prospective, observational cohort study of men and women with chronic kidney disease (CKD). The CRIC Clinical Centers will complete follow-up previously enrolled participants under a separate FOA with a focus on completing enrollment into ongoing sub-studies that utilize at-home assessments of kidney and cardiovascular function. T...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 21, 2022 Category: Research Source Type: funding
Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in Children Clinical Coordinating Centers (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-22-504 from the NIH Guide for Grants and Contracts. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in collaboration with the National Heart, Lung and Blood Institute (NHLBI) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), invites applications for a limited competition for the two Clinical Coordinating Centers (CCCs) already involved in The Chronic Kidney Disease in Children Study (CKiD) Consortium. The clinical centers will continue to evaluate enrolled participants, recruit new participants, and continue to work t...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 15, 2022 Category: Research Source Type: funding
Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-22-010 from the NIH Guide for Grants and Contracts. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in collaboration with the National Heart, Lung and Blood Institute (NHLBI) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), invites applications for the Central Biochemistry Laboratory (CBL) for the Chronic Kidney Disease in Children Study (CKiD) Consortium. The CBL will work cooperatively with the existing Clinical Coordinating Centers (CCCs) and the Data Coordinating Center (DCC) of the study as a consortium. (Source...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 15, 2022 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Preventive Interventions to Address Cardiometabolic Risk Factors in Populations that Experience Health Disparities
Notice NOT-OD-22-154 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 14, 2022 Category: Research Source Type: funding
NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)
Funding Opportunity PAR-22-194 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to use the NHLBI-funded TransOmics for Precision Medicine (TOPMed) program to generate a large volume of integrated genetic and multi-omics data to facilitate discovery of the molecular mechanisms of heart, lung, blood, and sleep (HLBS) disorders. The overall goal is to transition the program from genetic Map to Mechanism (M2) and to fill knowledge gaps that have not been sufficiently covered by existing TOPMed datasets. No funding will be provided under this FOA. The omics and rel...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 1, 2022 Category: Research Source Type: funding
Notice of Expiration of NOT-HL-19-677 "Notice of Special Interest SEARCH: Stimulating ExplorAtory Research on HIV/AIDS Contribution to Heart, Lung, Blood and Sleep Comorbidities (R01 - Clinical Trial Not Allowed)"
Notice NOT-HL-22-021 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 5, 2022 Category: Research Source Type: funding
Reducing Racial and Ethnic Healthcare Disparities in Chronic Conditions by Dissemination and Implementation of Patient Centered Outcomes Research (PCOR) Evidence (R18)
Funding Opportunity RFA-HS-22-001 from the NIH Guide for Grants and Contracts. The Agency for Healthcare Research and Quality (AHRQ) seeks applications to disseminate and implement patient-centered outcomes research (PCOR) findings into innovative, evidence-based interventions to reduce healthcare disparities in chronic health conditions. Applications to this Notice of Funding Opportunity (NOFO) are required to disseminate and implement PCOR findings across healthcare settings to address disparities in health outcomes and quality for racial and ethnic minority populations and AHRQ priority populations. Interventions mus...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 4, 2022 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Research on Barriers to Care and Risk of HIV-Associated Comorbidities among Vulnerable Population Groups
Notice of Special Interest for research that analyzes barriers to care and risk of HIV-associated comorbidities among disproportionally vulnerable and affected population groups of people living with or at risk for HIV infection. Geographic coverage: 57 priority jurisdictions including 7 states with a substantial rural HIV burden -- National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - February 1, 2022 Category: American Health Source Type: funding
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
Funding Opportunity RFA-HL-23-010 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits grant applications to further develop enabling technologies and transformative platforms to catalyze next-generation predictive, diagnostic and therapeutic products to address heart, lung, blood, and sleep (HLBS)-related disorders and diseases. This FOA solicits R33 applications where major feasibility gaps for the enabling technology or transformative platform have already been overcome, as demonstrated with supportive preliminary data, but still requires further development and rigorous v...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 24, 2022 Category: Research Source Type: funding
Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
Funding Opportunity RFA-HL-23-011 from the NIH Guide for Grants and Contracts. This Catalyze Product Definition Funding Opportunity Announcement (FOA) will provide the early stage translational support needed to identify and characterize potential therapeutic candidates to treat heart, lung, blood, and sleep diseases and disorders. This FOA is part of a suite of Catalyze innovation grants to advance projects to the point where they can meet the entry criteria for the NHLBI Catalyze Preclinical program or attract independent development support from other federal or private partners for preclinical optimization and devel...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 24, 2022 Category: Research Source Type: funding
Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed)
Funding Opportunity RFA-HL-23-012 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will provide the early stage translational support needed to identify a lead compound series toward development of potential therapeutic agents to treat heart, lung, blood, and sleep diseases and disorders. This FOA is part of a suite of Catalyze innovation grants to advance projects to the point where they can meet the entry criteria for the NHLBI Catalyze Preclinical program or attract independent development support from other federal or private partners for preclinical optimization and developme...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 24, 2022 Category: Research Source Type: funding
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
Funding Opportunity PAS-22-096 from the NIH Guide for Grants and Contracts. The Stimulating Hematology Investigation: New Endeavors (SHINE) program is intended to promote innovative, high-quality nonmalignant hematology research relevant to the missions of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Aging (NIA), and the National Heart, Lung, and Blood Institute (NHLBI). Investigator-initiated research project grant applications (R01s) in specific areas of basic and early translational hematology research are invited to this program that supports growth in the nonma...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 22, 2021 Category: Research Source Type: funding
